Tissue Diagnostics: Technologies and Global Markets

List of Tables

The global market for tissue diagnostics is estimated to increase from $8.9 billion in 2024 to reach $12.4 billion by 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 through 2029.

The reagents market for tissue diagnostics is estimated to increase from $6.6 billion in 2024 to reach $9.3 billion by 2029, at a CAGR of 6.9% from 2024 through 2029.

The instruments market for tissue diagnostics is estimated to increase from $2.2 billion in 2024 to reach $3.1 billion by 2029, at a CAGR of 7.0% from 2024 through 2029.

Report Scope

The report provides an analysis of the tissue diagnostics market, along with a competitive landscape and profiles of leading companies that include their revenues, product portfolios and recent activities. The report analyzes market dynamics, including drivers, limitations, challenges and opportunities, and discusses current and potential market size. The report will enable companies in the industry to make informed decisions about the production and licensing of goods and services. Organizations, distributors and exporters should find useful information about market developments and trends.

The study segments the market on multiple bases. By product type, the market is segmented into instruments and reagents (reagents/test kits/consumables of tissue diagnostics).

By segment type, the market is divided into histopathology, which includes hematoxylin and eosin stains (H&E) and immunohistochemistry (IHC); molecular pathology, which includes in situ hybridization (ISH), polymerase chain reaction (PCR) and next-generation sequencing (NGS); microbiological testing, which includes general culture testing and antimicrobial susceptibility testing and identification (AST/ID); and digital pathology.

Regional market analysis is provided for all the major segments. The regions are North America; Europe; Asia-Pacific; Latin America; and Rest of the World (RoW), which in this report consists of the Middle East and Africa. The report also provides country-level analyses of markets and market segments.

The report covers only tissue sample-based tests. The liquid biopsy market; swab, saliva and urine-based tests; and the service testing market of tissue diagnostics are outside the scope of the report.

In this report, the tissue diagnostics market is segmented by:

Product type:

Reagents.
Instruments.

Segments:

Histopathology (H&E, IHC).
Molecular pathology (ISH, PCR and NGS).
Microbiological testing (general culture testing, AST/ID testing) .
Digital pathology.

Technology:

H&E.
IHC.
ISH.
PCR.
NGS.
Digital pathology.

Applications:

Oncology.
Tissue typing.
Pathogen detection and AST.

End users:

Professional laboratories.
Emergency care units.
Academic and research institutes.

Report Includes

40 data tables and 42 additional tables
An analysis of the global market trends for tissue diagnostics, with market revenue data from 2022 to 2023, estimates for 2024, forecasts for 2025, and projected CAGRs through 2029
Estimates of the size and revenue prospects of the global market, along with a market share analysis by type of test, technology, application, end user and region
Facts and figures pertaining to the market dynamics, technical advances, regulations, and the impact of macroeconomic factors
Insights derived from the Porter's Five Forces model, as well as global supply chain and PESTLE analyses
An analysis of patents, emerging trends and developments in the industry
Analysis of the industry structure, including companies' market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
Company profiles of major players within the industry, including F. Hoffmann-La Roche Ltd., Danaher Corp., Agilent Technologies Inc., Thermo Fisher Scientific Inc., and Illumina Inc.

Product Code: MDS051B

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Market Summary

Chapter 2 Market Overview

Market Overview and Definitions
Immunohistochemistry (IHC)
In Situ Hybridization
Polymerase Chain Reaction
Next-Generation Sequencing
General Culture Testing

Chapter 3 Market Dynamics

Market Dynamics
Market Drivers
Increasing Incidence of Cancer Cases
Companion Diagnostics in Cancer Treatment
Importance of Early Cancer Testing
Raising Awareness of Early Signs of Cancer
Aging Population
Market Opportunities
Enhancing Access
Digital Pathology
Partnerships
Market Restraints
Cost of Tissue Diagnostic Tests
Competing Technologies
Turnaround Time
Market Challenges
Lack of Skilled Professionals
Complex Sample Preparation and Handling

Chapter 4 Emerging Technologies and Developments

Overview
Digital Pathology and AI Integration
3D Tissue Pathology and AI
Fluorescent In Situ Sequencing

Chapter 5 Tissue Diagnostics Testing Market

Segmentation Breakdown
Market Breakdown
Market Breakdown, by Product Type
Market Breakdown, by Technology
Market Breakdown, by Segment
Histopathology Market
Molecular Pathology Market
Microbiology Testing Market
Digital Pathology Market
Market Breakdown, by Application
Market Breakdown, by End User
Geographic Breakdown
Market Breakdown, by Region
North America
Europe
Asia-Pacific
Latin America
Rest of the World

Chapter 6 Competitive Intelligence

Industry Scenario
Competitive Landscape

Chapter 7 Sustainability in the Market for Tissue Diagnostics: An ESG Perspective

Introduction to ESG
Environmental Performance
Social Performance
Governance Performance
Concluding Remarks from BCC

Chapter 8 Appendix

Research Methodology
References
Acronyms
Company Profiles
ABBOTT
AGILENT TECHNOLOGIES INC.
BD
BIOCARE MEDICAL LLC.
BIOMERIEUX
BIO-RAD LABORATORIES INC.
DANAHER CORP.
F. HOFFMANN-LA ROCHE LTD.
ILLUMINA INC.
KONINKLIJKE PHILIPS N.V.
MERCK KGAA
MYRIAD GENETICS INC.
QIAGEN
THERMO FISHER SCIENTIFIC INC.
ZYTOVISION GMBH

Product Code: MDS051B

List of Tables

Summary Table : Global Tissue Diagnostics Market, by Product Type, Through 2029
Table 1 : Global Incidence of All Cancers, by Region, 2022-2045
Table 2 : Cancer Cases, by Country, 2022
Table 3 : Incidence of Cancer, by Cancer Type, 2022
Table 4 : Cancer Treatments Based on Specific Tests
Table 5 : Global Tissue Diagnostics Market, Through 2029
Table 6 : Global Tissue Diagnostics Market, by Product Type, Through 2029
Table 7 : Global Tissue Diagnostics Market, by Technology, Through 2029
Table 8 : Global IHC Tissue Diagnostics Market, by Region, Through 2029
Table 9 : Global H&E and Special Stains Diagnostics Market, by Region, Through 2029
Table 10 : Global ISH Tissue Diagnostics Market, by Region, Through 2029
Table 11 : Global PCR Tissue Diagnostics Market, by Region, Through 2029
Table 12 : Global NGS Tissue Diagnostics Market, by Region, Through 2029
Table 13 : Global Digital Pathology Market, by Region, Through 2029
Table 14 : Global Tissue Diagnostics Market, by Segment Type, Through 2029
Table 15 : Global Histopathology Market, by Product Type, Through 2029
Table 16 : Global Histopathology Market, by Region, Through 2029
Table 17 : Global Molecular Pathology Market, by Product Type, Through 2029
Table 18 : Global Molecular Pathology Market, by Region, Through 2029
Table 19 : Global Microbiology Testing Market, by Product Type, Through 2029
Table 20 : Global Microbiology Testing Market, by Region, Through 2029
Table 21 : Global Digital Pathology Market, Through 2029
Table 22 : Global Digital Pathology Market, by Region, Through 2029
Table 23 : Global Tissue Diagnostics Market, by Application, Through 2029
Table 24 : Global Tissue Diagnostics Market, by End User, Through 2029
Table 25 : Global Tissue Diagnostics Market, by Region, Through 2029
Table 26 : North American Tissue Diagnostics Market, by Country, Through 2029
Table 27 : European Tissue Diagnostics Market, by Country, Through 2029
Table 28 : Asia-Pacific Tissue Diagnostics Market, by Country, Through 2029
Table 29 : Latin American Tissue Diagnostics Market, by Country, Through 2029
Table 30 : RoW Tissue Diagnostics Market, Through 2029
Table 31 : ESG: Environmental Overview
Table 32 : ESG: Social Overview
Table 33 : ESG: Governance Overview
Table 34 : Acronyms Used in this Report
Table 35 : Abbott: Company Snapshot
Table 36 : Abbott: Financial Performance, FY 2022 and 2023
Table 37 : Abbott: Product Portfolio
Table 38 : Agilent Technologies Inc.: Company Snapshot
Table 39 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
Table 40 : Agilent Technologies Inc.: Product Portfolio
Table 41 : Agilent Technologies Inc.: News/Key Developments, 2024
Table 42 : BD: Company Snapshot
Table 43 : BD: Financial Performance, FY 2022 and 2023
Table 44 : BD: Product Portfolio
Table 45 : Biocare Medical LLC.: Company Snapshot
Table 46 : Biocare Medical LLC.: Product Portfolio
Table 47 : Biomerieux: Company Snapshot
Table 48 : Biomerieux: Financial Performance, FY 2022 and 2023
Table 49 : Biomerieux: Product Portfolio
Table 50 : Bio-Rad Laboratories Inc.: Company Snapshot
Table 51 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 52 : Bio-Rad Laboratories Inc.: Product Portfolio
Table 53 : Danaher Corp.: Company Snapshot
Table 54 : Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 55 : Danaher Corp.: Product Portfolio
Table 56 : Danaher Corp.: News/Key Developments, 2023
Table 57 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 58 : F. Hoffmann-La Roche Ltd.: Financials, FY 2022 and 2023
Table 59 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 60 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2024
Table 61 : Illumina Inc.: Company Snapshot
Table 62 : Illumina Inc.: Financial Performance, FY 2022 and 2023
Table 63 : Illumina Inc.: Product Portfolio
Table 64 : Illumina Inc.: News/Key Developments, 2024
Table 65 : Koninklijke Philips N.V.: Company Snapshot
Table 66 : Koninklijke Philips N.V.: Financial Performance, FY 2022 and 2023
Table 67 : Koninklijke Philips N.V.: Product Portfolio
Table 68 : Merck KGaA: Company Snapshot
Table 69 : Merck KGaA: Financial Performance, FY 2022 and 2023
Table 70 : Merck KGaA: Product Portfolio
Table 71 : Myriad Genetics Inc.: Company Snapshot
Table 72 : Myriad Genetics Inc.: Financial Performance, FY 2022 and 2023
Table 73 : Myriad Genetics Inc.: Product Portfolio
Table 74 : QIAGEN.: Company Snapshot
Table 75 : QIAGEN.: Financial Performance, FY 2022 and 2023
Table 76 : QIAGEN.: Product Portfolio
Table 77 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 78 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 79 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 80 : ZytoVision GmbH: Company Snapshot
Table 81 : ZytoVision GmbH: Product Portfolio

List of Figures

Summary Figure A : Global Tissue Diagnostics Market, by Product Type, 2021-2029
Summary Figure B : Shares of Global Market for Tissue Diagnostics, by Product Type, 2023
Figure 1 : Market Dynamics of Tissue Diagnostics
Figure 2 : Shares of All Cancer Cases, by Region, 2022
Figure 3 : Emerging Trends and Technologies in Tissue Diagnostics
Figure 4 : Shares of Global Market for Tissue Diagnostics, by Technology, 2023
Figure 5 : Shares of Global Market for Tissue Diagnostics, by Segment Type, 2023
Figure 6 : Shares of Global Market for Histopathology, by Product Type, 2023
Figure 7 : Shares of Global Market for Molecular Pathology, by Product Type, 2023
Figure 8 : Shares of Global Market for Microbiology Testing, by Product Type, 2023
Figure 9 : Shares of Global Market for Tissue Diagnostics, by Application, 2023
Figure 10 : Shares of Global Market for Tissue Diagnostics, by End User, 2023
Figure 11 : Shares of Global Market for Tissue Diagnostics, by Region, 2023
Figure 12 : Shares of North American Market for Tissue Diagnostics, by Country, 2023
Figure 13 : Shares of European Market for Tissue Diagnostics, by Country, 2023
Figure 14 : Shares of Asia-Pacific Market for Tissue Diagnostics, by Country, 2023
Figure 15 : Shares of Latin American Tissue Diagnostics Market, by Country, 2023
Figure 16 : Shares of Global Market for Tissue Diagnostics, by Company, 2023
Figure 17 : ESG Pillars
Figure 18 : Advantages of ESG for Companies
Figure 19 : Abbott: Revenue Shares, by Business Unit, FY 2023
Figure 20 : Abbott: Revenue Shares, by Country/Region, FY 2023
Figure 21 : Agilent Technologies Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 22 : Agilent Technologies Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 23 : BD: Revenue Shares, by Business Unit, FY 2023
Figure 24 : BD: Revenue Shares, by Country/Region, FY 2023
Figure 25 : Biomerieux: Revenue Shares, by Business Unit, FY 2023
Figure 26 : Biomerieux: Revenue Shares, by Country/Region, FY 2023
Figure 27 : Bio-Rad Laboratories Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 28 : Bio-Rad Laboratories Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 29 : Danaher Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 30 : Danaher Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 31 : F. Hoffmann-La Roche Ltd.: Revenue Shares, by Business Unit, FY 2023
Figure 32 : F. Hoffmann-La Roche Ltd.: Revenue Shares, by Country/Region, FY 2023
Figure 33 : Illumina Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 34 : Illumina Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 35 : Koninklijke Philips N.V.: Revenue Shares, by Business Unit, FY 2023
Figure 36 : Koninklijke Philips N.V.: Revenue Shares, by Country/Region, FY 2023
Figure 37 : Merck KGaA: Market Shares, by Business Unit, FY 2023
Figure 38 : Merck KGaA: Revenue Shares, by Country/Region, FY 2023
Figure 39 : Myriad Genetics Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 40 : Myriad Genetics Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 41 : QIAGEN.: Revenue Shares, by Business Unit, FY 2023
Figure 42 : QIAGEN.: Revenue Shares, by Country/Region, FY 2023
Figure 43 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 44 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2023

Tissue Diagnostics: Technologies and Global Markets

Description

Table of Contents

List of Tables

Report Scope

Report Includes

Table of Contents

Chapter 1 Executive Summary

Chapter 2 Market Overview

Chapter 3 Market Dynamics

Chapter 4 Emerging Technologies and Developments

Chapter 5 Tissue Diagnostics Testing Market

Chapter 6 Competitive Intelligence

Chapter 7 Sustainability in the Market for Tissue Diagnostics: An ESG Perspective

Chapter 8 Appendix

List of Tables

List of Figures